Galera Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Galera Therapeutics

09/11/2022 13:18

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted
loss of 60 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 52 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galera Therapeutics Inc's reported EPS for the quarter was
a
loss of 60 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Galera Therapeutics Inc shares had fallen by 4.6% this
quarter and lost 63.8% so far this year.
    * The company reported a quarterly loss of $16.03 million.
    * Wall Street's median 12-month price target for Galera
Therapeutics Inc is $12.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 01:18 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.52          -0.60          Missed
 Jun. 30 2022      -0.53          -0.54          Missed
 Mar. 31 2022      -0.57          -0.58          Missed
 Dec. 31 2021      -0.75          -0.64          Beat